Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 USD | +2.57% | +0.33% | -39.03% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.03% | 3.67B | |
+47.03% | 56.87B | |
+37.66% | 39.72B | |
-5.74% | 39.27B | |
-4.42% | 28.73B | |
+13.60% | 26.21B | |
-16.64% | 19.79B | |
+32.71% | 12.28B | |
+27.15% | 12.23B | |
+1.53% | 12.12B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Transcript : Immunovant, Inc. - Special Call